PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In two different studies performed in elderly patients (mean age around 70 years) with type 2 diabetes, Mantovani and colleagues [19,31] found lower eGFR and higher prevalence of CKD in those carrying the PNPLA3 rs738409 polymorphism, independently from NAFLD.